Robert Brockett

458 total citations
10 papers, 333 citations indexed

About

Robert Brockett is a scholar working on Molecular Biology, Epidemiology and Surgery. According to data from OpenAlex, Robert Brockett has authored 10 papers receiving a total of 333 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Robert Brockett's work include Liver Disease Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Robert Brockett is often cited by papers focused on Liver Disease Diagnosis and Treatment (4 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). Robert Brockett collaborates with scholars based in United States. Robert Brockett's co-authors include Andrew E. Greenstein, Ryu Watanabe, Cornelia M. Weyand, Hui Zhang, Toshihisa Maeda, Lü Tian, Gerald J. Berry, Markus Zeisbrich, Jörg J. Goronzy and Igor Mikaelian and has published in prestigious journals such as Blood, PLoS ONE and Circulation Research.

In The Last Decade

Robert Brockett

9 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Brockett United States	4	117	97	85	65	64	10	333
Jacob Hull Kristensen Denmark	7	96 0.8×	159 1.6×	99 1.2×	51 0.8×	104 1.6×	11	441
Ashish Manne United States	10	47 0.4×	100 1.0×	57 0.7×	85 1.3×	34 0.5×	44	430
Yuichiro Uchida Japan	14	122 1.0×	77 0.8×	86 1.0×	57 0.9×	47 0.7×	57	467
Ofer Ben Izhak Israel	9	89 0.8×	62 0.6×	132 1.6×	66 1.0×	37 0.6×	14	395
Min Feng China	14	72 0.6×	79 0.8×	129 1.5×	165 2.5×	20 0.3×	38	496
Keum Ha Choi South Korea	13	89 0.8×	122 1.3×	137 1.6×	22 0.3×	53 0.8×	48	443
Hideki Makino Japan	11	40 0.3×	170 1.8×	96 1.1×	67 1.0×	27 0.4×	33	419
Sabrina Ingrao Italy	13	74 0.6×	49 0.5×	211 2.5×	72 1.1×	43 0.7×	24	522
Valeria Maffeis Italy	11	77 0.7×	51 0.5×	81 1.0×	27 0.4×	31 0.5×	21	360
Boyang Chang China	12	38 0.3×	94 1.0×	142 1.7×	84 1.3×	70 1.1×	26	458

Countries citing papers authored by Robert Brockett

Since Specialization

Citations

This map shows the geographic impact of Robert Brockett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Brockett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Brockett more than expected).

Fields of papers citing papers by Robert Brockett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Brockett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Brockett. The network helps show where Robert Brockett may publish in the future.

Co-authorship network of co-authors of Robert Brockett

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Brockett. A scholar is included among the top collaborators of Robert Brockett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Brockett. Robert Brockett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Frigerio, Carlo Sala, Ali Ebrahimi, Jacqueline A. Brosnan‐Cashman, et al.. (2024). THU-203 Integrated spatial transcriptomics and machine learning derived histopathology measurements in steatotic liver disease unmasks biological heterogeneity of steatosis. Journal of Hepatology. 80. S567–S567. 1 indexed citations

O’Sullivan, Chris, Robert Brockett, Amanda Mikels‐Vigdal, et al.. (2023). Characterization of Active MMP9 in Chronic Inflammatory Diseases Using a Novel Anti-MMP9 Antibody. Antibodies. 12(1). 9–9. 11 indexed citations

Bates, Jamie, Archana Vijayakumar, Sarani Ghoshal, et al.. (2020). Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation. Journal of Hepatology. 73(4). 896–905. 154 indexed citations

Bates, Jamie, David Hollenback, Anna Zagórska, et al.. (2018). Combination of an FXR agonist and an ACC inhibitor increases anti-fibrotic efficacy in rodent models of NASH. Journal of Hepatology. 68. S395–S396.

Watanabe, Ryu, Toshihisa Maeda, Hui Zhang, et al.. (2018). MMP (Matrix Metalloprotease)-9–Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis. Circulation Research. 123(6). 700–715. 121 indexed citations

Wei, Ling, David Hollenback, Saritha Kusam, et al.. (2018). ACC inhibitor demonstrates potent anti-fibrotic activity in vitro and in vivo. Journal of Hepatology. 68. S399–S400. 2 indexed citations

Meadows, Sarah, Rick Sorensen, Zhi-Hua Cui, et al.. (2017). PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors. PLoS ONE. 12(2). e0171221–e0171221. 38 indexed citations

Zagórska, Anna, David Hollenback, Grant R. Budas, et al.. (2017). Combination of an ASK1 inhibitor and FXR agonist increases efficacy in a mouse model of non-alcoholic steatohepatitis. Journal of Hepatology. 66(1). S19–S20. 3 indexed citations

Bates, Jamie, Robert Brockett, I. Mikaelian, et al.. (2017). A liver-targeted acetyl CoA carboxylase inhibitor reduces hepatic steatosis and liver injury in a murine model of NASH. Journal of Hepatology. 66(1). S430–S430. 1 indexed citations

10.

Meadows, Sarah, Rick Sorensen, Zhi-Hua Cui, et al.. (2016). Evaluation of Idelalisib with B-Cell Receptor or Orthogonal Pathway Inhibitors in Diffuse Large B-Cell Lymphoma Cell Lines in Vitro and In Vivo. Blood. 128(22). 1845–1845. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact